| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Cellectar Biosciences, Inc. (CLRB) has 4 insiders with recent SEC Form 4 filings, including 9 buys and 1 sell. CLRB is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| COO | 12.8K | $39.2K | - | |
| CEO | 11.6K | $35.7K | - | |
| CFO | 6.4K | $19.7K | - | |
| Dir | 10 | $30.70 | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 12, 2025 | Neis John | Director | Sell | 198 | $3.70 | $731.99 | -95.2% | -10.8% | - | |
| Jul 2, 2025 | Caruso James V | Chief Executive Officer | Buy | 10,000 | $4.99 | $49,900.00 | +610.5% | +18.4% | - | |
| Jul 2, 2025 | Longcor Jarrod | Chief Operating Officer | Buy | 10,000 | $4.99 | $49,900.00 | +361.3% | +18.4% | - | |
| Jul 2, 2025 | Kolean Chad J | Chief Financial Officer | Buy | 5,000 | $4.99 | $24,950.00 | +352.6% | +18.4% | - | |
| Jan 10, 2025 | Longcor Jarrod | Chief Operating Officer | Buy | 30,000 | $0.28 | $8,400.00 | +56.5% | -3.4% | -63.6% | |
| Sep 14, 2021 | Swirsky Douglas J | Director | Buy | 25,000 | $1.04 | $26,000.00 | New | -30.8% | -56.1% | |
| Sep 3, 2021 | Driscoll Frederick W | Director | Buy | 19,417 | $1.04 | $20,244.16 | New | -36.3% | -49.1% | |
| Mar 4, 2021 | Caruso James V | President And CEO | Buy | 5,100 | $1.70 | $8,658.78 | +6.3% | - | - | |
| Dec 28, 2020 | Caruso James V | President And CEO | Buy | 37,037 | $1.35 | $49,999.95 | +83.7% | - | - | |
| Dec 28, 2020 | Longcor Jarrod | Chief Business Officer | Buy | 29,630 | $1.35 | $40,000.50 | +40.9% | - | - |